Skip to content

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Prospective Longitudenal Study in the Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01255202
Enrollment
200
Registered
2010-12-07
Start date
2009-09-30
Completion date
2011-12-31
Last updated
2010-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia/Toxemia

Keywords

preeclampsia, toxemia, twin, pregnancy, pp13, prediction, kongo red

Brief summary

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.

Interventions

None listed

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* a women with a vaiable twin pregnany

Exclusion criteria

* women with thrombophilya * women terated with anticoagolant * women with vascular disease

Countries

Israel

Contacts

Primary ContactRan Svirsky, MD
rsvirs@gmail.com972-8-9779000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026